These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23645773)

  • 1. The mRNA expression of inhibitors of DNA binding-1 and -2 is associated with advanced tumour stage and adverse clinical outcome in human breast cancer.
    Wazir U; Jiang WG; Sharma AK; Newbold RF; Mokbel K
    Anticancer Res; 2013 May; 33(5):2179-83. PubMed ID: 23645773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P14ARF is down-regulated during tumour progression and predicts the clinical outcome in human breast cancer.
    Wazir U; Jiang WG; Yasaei H; Linne H; Newbold RF; Mokbel K
    Anticancer Res; 2013 May; 33(5):2185-9. PubMed ID: 23645774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
    de Candia P; Akram M; Benezra R; Brogi E
    Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level.
    Xu C; Yamamoto-Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Okumura Y; Yamaguchi L; Fujiki Y; Iwase H
    Breast Cancer; 2014 Jul; 21(4):482-90. PubMed ID: 22968628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High TIMM17A expression is associated with adverse pathological and clinical outcomes in human breast cancer.
    Salhab M; Patani N; Jiang W; Mokbel K
    Breast Cancer; 2012 Apr; 19(2):153-60. PubMed ID: 20972741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel prognostic markers for patients with triple-negative breast cancer.
    Zhou L; Li K; Luo Y; Tian L; Wang M; Li C; Huang Q
    Hum Pathol; 2013 Oct; 44(10):2180-7. PubMed ID: 23845466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear localization of GLI1 and elevated expression of FOXC2 in breast cancer is associated with the basal-like phenotype.
    Li Y; Yang W; Yang Q; Zhou S
    Histol Histopathol; 2012 Apr; 27(4):475-84. PubMed ID: 22374725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular markers of therapeutic resistance in breast cancer.
    Zhou L; Luo Y; Li K; Tian L; Wang M; Li C; Huang Q
    Hum Pathol; 2013 Jul; 44(7):1421-8. PubMed ID: 23434145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of angio-associated migratory cell protein (AAMP) on breast cancer cells in vitro and its clinical significance.
    Yin Y; Sanders AJ; Jiang WG
    Anticancer Res; 2013 Apr; 33(4):1499-509. PubMed ID: 23564791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.
    Badve S; Turbin D; Thorat MA; Morimiya A; Nielsen TO; Perou CM; Dunn S; Huntsman DG; Nakshatri H
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4415-21. PubMed ID: 17671124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of protein expression and DNA methylation profiles detected by pyrosequencing in invasive breast cancer.
    Zmetakova I; Danihel L; Smolkova B; Mego M; Kajabova V; Krivulcik T; Rusnak I; Rychly B; Danis D; Repiska V; Blasko P; Karaba M; Benca J; Pechan J; Fridrichova I
    Neoplasma; 2013; 60(6):635-46. PubMed ID: 23906298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of transcription factor CREB1 in human breast cancer and its correlation with prognosis.
    Chhabra A; Fernando H; Watkins G; Mansel RE; Jiang WG
    Oncol Rep; 2007 Oct; 18(4):953-8. PubMed ID: 17786359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer.
    Grönberg M; Fjällskog ML; Jirström K; Janson ET
    Acta Oncol; 2012 Mar; 51(3):386-93. PubMed ID: 22067021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer.
    Lanigan F; McKiernan E; Brennan DJ; Hegarty S; Millikan RC; McBryan J; Jirstrom K; Landberg G; Martin F; Duffy MJ; Gallagher WM
    Int J Cancer; 2009 May; 124(9):2088-97. PubMed ID: 19142967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discordant HER2 status between primary breast carcinoma and recurrent/metastatic tumors using fluorescence in situ hybridization on cytological samples.
    Arihiro K; Oda M; Ogawa K; Tominaga K; Kaneko Y; Shimizu T; Matsumoto S; Oda M; Kurita Y; Taira Y
    Jpn J Clin Oncol; 2013 Jan; 43(1):55-62. PubMed ID: 23225912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of the human antigen R (HuR) in human breast cancer: high level predicts a favourable prognosis.
    Yuan Z; Sanders AJ; Ye L; Wang Y; Jiang WG
    Anticancer Res; 2011 Jan; 31(1):303-10. PubMed ID: 21273615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential prognostic biomarker CD73 regulates epidermal growth factor receptor expression in human breast cancer.
    Zhi X; Wang Y; Yu J; Yu J; Zhang L; Yin L; Zhou P
    IUBMB Life; 2012 Nov; 64(11):911-20. PubMed ID: 23086814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of PRL-3, Snail, Cytokeratin and Vimentin expression in epithelial mesenchymal transition in breast carcinoma.
    Patel NA; Patel PS; Vora HH
    Breast Dis; 2015; 35(2):113-27. PubMed ID: 25547164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capillary morphogenesis gene 2 inhibits growth of breast cancer cells and is inversely correlated with the disease progression and prognosis.
    Ye L; Sun PH; Malik MF; Mason MD; Jiang WG
    J Cancer Res Clin Oncol; 2014 Jun; 140(6):957-67. PubMed ID: 24667935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic values of the inhibitor of DNA‑binding family members in breast cancer.
    Zhou XL; Zeng D; Ye YH; Sun SM; Lu XF; Liang WQ; Chen CF; Lin HY
    Oncol Rep; 2018 Oct; 40(4):1897-1906. PubMed ID: 30066902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.